EMD-62786

Single-particle
3.1 Å
EMD-62786
3D View Gallery
Deposition: 18/12/2024
Map released: 11/03/2026
Last modified: 11/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62786
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9l3i summary report (pdf.gz) Map and 9l3i FULL report (pdf.gz)
EMICSS annotations (xml)

Cryo-EM structure of SARS-CoV-2 BA.2.75 Spike Protein complex with a potent broad-spectrum macrocyclic peptide inhibitor 6L3-3P11K

EMD-62786

Single-particle
3.1 Å
EMD-62786
3D View Gallery
Deposition: 18/12/2024
Map released: 11/03/2026
Last modified: 11/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, synthetic construct
Sample: SARS-CoV-2 BA.2.75 Spike Protein complex with a potent broad-spectrum macrocyclic peptide inhibitor 6L3-3P11K
Fitted models: 9l3i

Deposition Authors: Wang M, Yang JY, Peng Q, Shi Y
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.
Wang M, Yang J, Tan Y, Yuan S, Shi G, Peng Q, Li Y, Poon VK, Chan CC, Xiao N, Zhang AJ, Xie Y, Li J, Luo H, Fu Y, Chen Y, Compton AA, Zhang Y, Yang Y, Gao GF, Hou H, Chan JF, Yin Y, Shi Y
(2026) Nat Commun , 17 , 1753 - 1753
PUBMED: 41587975
DOI: doi:10.1038/s41467-026-68462-9
ISSN: 2041-1723